Danazol
book-chapter
OA: closed
CC0
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper explores the use of danazol, a synthetic steroid, in treating various gynecological conditions by modulating hormonal pathways.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (15)
- Danazol for heavy menstrual bleeding via openalex
- Danazol for pelvic pain associated with endometriosis via openalex
- Danazol for unexplained subfertility via openalex
- Danazol induced cholestasis: pathogenetic hypothesis. via openalex
- Danazol‐induced hepatocellular carcinoma via openalex
- Danazol treatment and acute myocardial infarction via openalex
- Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group study via openalex
- Rapidly Progressive Pulmonary Fibrosis in a Patient Treated with Danazol for Idiopathic Thrombocytopenic Purpura via openalex
- doi:10.2165/00002512-200320110-00005 via openalex
- W6605936116 via openalex
- W6694090888 via openalex
- W6824378097 via openalex
- doi:10.1016/j.atherosclerosis.2007.09.025 via openalex
- doi:10.1016/j.jaci.2004.12.1130 via openalex
- doi:10.2340/00015555-0057 via openalex
Source provenance
- openalex
- last seen: 2026-05-10T10:24:32.001146+00:00
License: CC0
· commercial use OK